Understand what your pcos results really mean
See your biomarkers in context with a comprehensive panel.
- CLIA-certified labs
- HIPAA compliant
- Personalized health protocol
You've been diagnosed with polycystic ovary syndrome, started treatment, and yet your symptoms persist while someone else with the same diagnosis sees dramatic improvement on a completely different protocol. The frustration is real, and the confusion is understandable. PCOS isn't a single condition with a universal solution. It's a syndrome with multiple underlying drivers, each requiring its own approach. Understanding which type you have changes everything about how you manage it.
What PCOS types actually mean for your body
The term "PCOS types" refers to functional classifications based on what's driving your androgen excess and ovulatory dysfunction. While the Rotterdam criteria diagnose PCOS when two of three features are present (hyperandrogenism, ovulatory dysfunction, polycystic ovarian morphology), they don't tell you why those features exist. The four functional types identify the root cause: insulin resistance, chronic inflammation, adrenal stress response, or temporary hormonal suppression from birth control.
These aren't official medical subtypes in the way that type 1 and type 2 diabetes are distinct diseases. They're clinical patterns that help practitioners understand which metabolic or hormonal pathway is most disrupted. A woman with insulin-resistant PCOS has elevated insulin driving ovarian androgen production. Someone with inflammatory PCOS has cytokine imbalances triggering hormonal disruption. Adrenal PCOS involves the stress hormone pathway producing excess DHEA-S. Post-pill PCOS represents temporary hormonal suppression after stopping contraceptives, not true PCOS at all.
Understanding your type matters because metformin helps insulin resistance but does nothing for adrenal androgens. Anti-inflammatory interventions address inflammatory PCOS but won't resolve post-pill hormone recovery.
PCOS vs ovarian cysts: Clearing up the confusion
The difference between PCOS and ovarian cysts is fundamental but frequently misunderstood. PCOS is a metabolic and hormonal syndrome that results in substantial hormonal imbalance, affecting insulin sensitivity, androgen levels, and ovulation. The "cysts" in PCOS aren't true cysts at all. They're multiple small follicles (up to 8mm) that represent arrested egg development due to hormonal dysfunction.
Ovarian cysts, by contrast, are fluid-filled sacs that can develop for various reasons unrelated to PCOS. Functional cysts form during normal ovulation and typically resolve on their own. Other cysts may result from endometriosis, infection, or abnormal cell growth. A woman can have ovarian cysts without PCOS, and crucially, she can have PCOS without visible cysts on ultrasound.
PCOD (polycystic ovarian disease) is an older term sometimes used interchangeably with PCOS, though it's less precise. PCOD typically refers to the ovarian morphology alone, while PCOS encompasses the full syndrome including metabolic and hormonal features.
How each PCOS type affects your hormones and metabolism
Insulin-resistant PCOS
This is the most common form, present in approximately 50 to 70% of PCOS cases. Insulin resistance means your cells don't respond efficiently to insulin, forcing your pancreas to produce more. Elevated insulin directly stimulates ovarian theca cells to produce androgens, particularly testosterone. It also suppresses sex hormone-binding globulin (SHBG), leaving more free testosterone circulating. Insulin resistance exists independent of body weight, though excess weight worsens it.
Inflammatory PCOS
Chronic low-grade inflammation drives this type, characterized by elevated inflammatory markers including high-sensitivity C-reactive protein, interleukin-6, and tumor necrosis factor-alpha. Inflammation disrupts normal ovarian function and increases androgen production through pathways distinct from insulin resistance. This type can occur in women of any weight and doesn't necessarily correlate with metabolic dysfunction. The inflammatory state creates a feedback loop: inflammation worsens insulin resistance, and insulin resistance promotes more inflammation.
Adrenal PCOS
Approximately 20 to 30% of women with PCOS have elevated DHEA-S (dehydroepiandrosterone sulfate), an androgen produced by the adrenal glands rather than the ovaries. This form is driven by the hypothalamic-pituitary-adrenal (HPA) axis response to stress. When you experience chronic stress, your adrenal glands release cortisol and, inadvertently, DHEA-S. Unlike other PCOS types, testosterone and androstenedione may be normal while DHEA-S is elevated.
Post-pill PCOS
This isn't true PCOS but rather a temporary state of hormonal suppression following discontinuation of hormonal birth control. The pill suppresses your natural hormone production, and when you stop, it can take months for your hypothalamic-pituitary-ovarian axis to resume normal function. During this recovery period, you may experience irregular periods, anovulation, and temporary androgen elevation that mimics PCOS. The key difference: these symptoms resolve on their own, typically within three to six months.
What drives each type of PCOS
Insulin-resistant PCOS drivers
Genetics play a significant role, with family history of type 2 diabetes increasing risk. Diet high in refined carbohydrates and added sugars worsens insulin resistance by creating repeated blood sugar spikes. Sedentary lifestyle reduces muscle glucose uptake, one of the primary mechanisms for clearing glucose from blood. Excess visceral fat produces inflammatory cytokines that interfere with insulin signaling. Sleep deprivation and chronic stress elevate cortisol, which antagonizes insulin action.
Inflammatory PCOS drivers
Gut dysbiosis and increased intestinal permeability allow bacterial endotoxins to enter circulation, triggering systemic inflammation. Food sensitivities, particularly to gluten and dairy in susceptible individuals, activate immune responses. Environmental toxins including BPA, phthalates, and pesticides disrupt endocrine function and promote inflammation. Oxidative stress from poor diet, smoking, or inadequate antioxidant intake damages cells and triggers inflammatory cascades. Lack of omega-3 fatty acids relative to omega-6 creates a pro-inflammatory state.
Adrenal PCOS drivers
Chronic psychological stress from work, relationships, or financial pressure keeps the HPA axis activated. Over-exercise without adequate recovery stresses the adrenal system. Under-eating or restrictive dieting signals starvation stress to the body. Poor sleep quality or insufficient sleep duration disrupts cortisol rhythms and increases DHEA-S production. Blood sugar instability from irregular eating patterns creates metabolic stress. Some women have heightened adrenal sensitivity to ACTH (adrenocorticotropic hormone), producing more DHEA-S in response to normal stress levels.
Post-pill PCOS drivers
This is purely a consequence of hormonal contraceptive use. The pill suppresses GnRH (gonadotropin-releasing hormone) from the hypothalamus, which in turn suppresses FSH and LH from the pituitary. Without these signals, the ovaries stop producing normal amounts of estrogen and progesterone. When you stop the pill, it takes time for this axis to wake up. Nutrient deficiencies created by the pill, particularly B vitamins, magnesium, and zinc, can prolong recovery time.
Why the same treatment doesn't work for everyone
Genetic variations affect how you metabolize hormones, respond to insulin, and process inflammation. Some women have gene variants that make them poor responders to metformin. Others have heightened inflammatory responses to specific foods that wouldn't affect someone else. Your gut microbiome composition influences hormone metabolism, with certain bacterial strains either promoting or reducing androgen levels.
Prior dieting history matters. Women with a history of restrictive eating or yo-yo dieting often have metabolic adaptation that makes weight loss more difficult and can worsen hormonal imbalances. Muscle mass is a critical variable: more muscle means better insulin sensitivity and glucose disposal, regardless of body weight.
Thyroid function affects PCOS presentation and treatment response. Subclinical hypothyroidism worsens insulin resistance and makes weight management harder. Stress resilience varies based on HPA axis sensitivity, past trauma, and current life circumstances. Age and reproductive stage influence hormone levels and treatment goals. The presence of other conditions like endometriosis, adenomyosis, or autoimmune disease complicates the picture.
Test 100+ biomarkers from home
One blood draw. A full picture of your health, explained in plain language.
Test 100+ biomarkers from home
One blood draw. A full picture of your health, explained in plain language.
Matching your PCOS type to the right treatment strategy
Identifying your type through testing
Comprehensive testing reveals your PCOS type. Fasting insulin and glucose reveal insulin resistance. Hemoglobin A1c shows longer-term glucose control. High-sensitivity CRP indicates inflammatory status. Total and free testosterone, DHEA-S, and androstenedione identify which androgens are elevated. SHBG shows how much testosterone is bioavailable.
Insulin-resistant PCOS interventions
Metformin improves insulin sensitivity by reducing hepatic glucose production and enhancing cellular glucose uptake, which may support ovulation in some women. Dietary interventions focusing on low-glycemic foods, adequate protein, and fiber help stabilize blood sugar by slowing glucose absorption. Strength training builds muscle mass, which acts as a glucose sink by increasing insulin-independent glucose uptake during contraction. Berberine and inositol supplements activate AMPK pathways that improve insulin sensitivity.
Inflammatory PCOS interventions
Anti-inflammatory dietary patterns emphasizing omega-3 fatty acids, colorful vegetables, and polyphenol-rich foods reduce inflammatory cytokine production. Eliminating or reducing inflammatory triggers like processed foods, excess omega-6 oils, and potential food sensitivities decreases immune activation. Curcumin may help inhibit NF-kB inflammatory pathways, while omega-3 supplementation shifts eicosanoid production toward anti-inflammatory mediators. N-acetylcysteine supports glutathione production, which may help reduce oxidative stress. Addressing gut health with probiotics reduces endotoxin translocation that triggers systemic inflammation.
Adrenal PCOS interventions
Stress management is the primary intervention, as addressing psychological stress through therapy, meditation, or other techniques reduces HPA axis activation. Moderating exercise intensity and ensuring adequate recovery prevents cortisol elevation from overtraining. Eating regularly maintains stable blood sugar, preventing the cortisol release triggered by hypoglycemia. Adaptogenic herbs like ashwagandha and rhodiola modulate cortisol response to stress. Prioritizing sleep quality allows HPA axis recovery through proper circadian rhythm restoration.
Post-pill PCOS interventions
Time and nutritional support facilitate hormone recovery. Replenishing nutrients depleted by the pill, including B vitamins, magnesium, and zinc, provides cofactors necessary for steroid hormone synthesis. Supporting liver detoxification through adequate protein, cruciferous vegetables, and hydration enhances clearance of synthetic hormones. Most importantly, patience: if symptoms don't resolve within 6-12 months, underlying PCOS likely exists and requires appropriate treatment.
Addressing overlapping types
Many women have overlapping types. Someone might have both insulin resistance and inflammation, requiring a combined approach. Testing helps prioritize which driver is most significant. Tracking symptoms and biomarkers over time shows whether interventions are working.
If you're working to understand your PCOS type and optimize your metabolic health, Superpower's 100+ biomarker panel gives you the complete hormonal and metabolic picture you need to identify your specific drivers and track your progress with precision.
Frequently Asked Questions
References
- Amisi CA (2022). Markers of insulin resistance in Polycystic ovary syndrome women: An update. *World journal of diabetes*, *13*(3), 129-149. https://doi.org/10.4239/wjd.v13.i3.129
- Gambone JC, Mittman BS, Munro MG, Scialli AR, Winkel CA, Chronic Pelvic Pain/Endometriosis Working Group (2002). Consensus statement for the management of chronic pelvic pain and endometriosis: proceedings of an expert-panel consensus process. *Fertility and sterility*, *78*(5), 961-72. https://doi.org/10.1016/s0015-0282(02)04216-4
- Kumar A, Woods KS, Bartolucci AA, Azziz R (2005). Prevalence of adrenal androgen excess in patients with the polycystic ovary syndrome (PCOS). *Clinical endocrinology*, *62*(6), 644-9. https://doi.org/10.1111/j.1365-2265.2005.02256.x
- Abdalla MA, Shah N, Deshmukh H, Sahebkar A, Östlundh L, Al-Rifai RH, Atkin SL, Sathyapalan T (2022). Impact of metformin on the clinical and metabolic parameters of women with polycystic ovary syndrome: A systematic review and meta-analysis of randomised controlled trials. *Therapeutic Advances in Endocrinology and Metabolism*, *13*, 20420188221127142. https://doi.org/10.1177/20420188221127142
- Kite C, Lahart IM, Afzal I, Broom DR, Randeva H, Kyrou I, Brown JE (2019). Exercise, or exercise and diet for the management of polycystic ovary syndrome: A systematic review and meta-analysis. *Systematic reviews*, *8*(1), 51. https://doi.org/10.1186/s13643-019-0962-3
